Nuevas proteínas de hemaglutinina 5 (H5) para tratamiento y prevención de infecciones gripales

Nuevas proteínas de hemaglutinina 5 (H5) para tratamiento y prevención de infecciones gripales

Una vacuna que comprende a) proteína H5 del virus gripal, en el que la proteína H5 consiste en o comprende una cualquiera de las secuencias expresadas en SEQ ID NOs: 2 a 12, o 35 o 36 o 40; b) un vehículo y/o excipiente farmacéuticamente aceptable. The present invention relates to novel hemagglutini...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GONZALEZ-HERNANDEZ, Paulino Carlos, REALPE-QUINTERO, Mauricio Alberto, STADLER, Konrad, VAUGHN, Eric Martin, LEON KEMPIS, Maria del Rocio
Format: Patent
Sprache:spa
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GONZALEZ-HERNANDEZ, Paulino Carlos
REALPE-QUINTERO, Mauricio Alberto
STADLER, Konrad
VAUGHN, Eric Martin
LEON KEMPIS, Maria del Rocio
description Una vacuna que comprende a) proteína H5 del virus gripal, en el que la proteína H5 consiste en o comprende una cualquiera de las secuencias expresadas en SEQ ID NOs: 2 a 12, o 35 o 36 o 40; b) un vehículo y/o excipiente farmacéuticamente aceptable. The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals, in particular for the treatment and prevention of influenza infections with H5N1 of North African origin.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2798326TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2798326TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2798326TT33</originalsourceid><addsrcrecordid>eNqNizEOgkAUBWksjHqHb6eFDQTR2mCobKTHn_WBm8Dfze5C4qGsPAIXExMPYDVTzMyj26XHwJ6sMwHjSya9gx7ouGn7oEULU0qbIt2SZccUHAfuNCQYek4XBojS41u-m5YaSmkj8NQ4bbmFX0azmluP1Y-LaH3Oy1OxgzUVvGUFQajya5wdD0m8L8sk-af5ACLPPn4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Nuevas proteínas de hemaglutinina 5 (H5) para tratamiento y prevención de infecciones gripales</title><source>esp@cenet</source><creator>GONZALEZ-HERNANDEZ, Paulino Carlos ; REALPE-QUINTERO, Mauricio Alberto ; STADLER, Konrad ; VAUGHN, Eric Martin ; LEON KEMPIS, Maria del Rocio</creator><creatorcontrib>GONZALEZ-HERNANDEZ, Paulino Carlos ; REALPE-QUINTERO, Mauricio Alberto ; STADLER, Konrad ; VAUGHN, Eric Martin ; LEON KEMPIS, Maria del Rocio</creatorcontrib><description>Una vacuna que comprende a) proteína H5 del virus gripal, en el que la proteína H5 consiste en o comprende una cualquiera de las secuencias expresadas en SEQ ID NOs: 2 a 12, o 35 o 36 o 40; b) un vehículo y/o excipiente farmacéuticamente aceptable. The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals, in particular for the treatment and prevention of influenza infections with H5N1 of North African origin.</description><language>spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201210&amp;DB=EPODOC&amp;CC=ES&amp;NR=2798326T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20201210&amp;DB=EPODOC&amp;CC=ES&amp;NR=2798326T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GONZALEZ-HERNANDEZ, Paulino Carlos</creatorcontrib><creatorcontrib>REALPE-QUINTERO, Mauricio Alberto</creatorcontrib><creatorcontrib>STADLER, Konrad</creatorcontrib><creatorcontrib>VAUGHN, Eric Martin</creatorcontrib><creatorcontrib>LEON KEMPIS, Maria del Rocio</creatorcontrib><title>Nuevas proteínas de hemaglutinina 5 (H5) para tratamiento y prevención de infecciones gripales</title><description>Una vacuna que comprende a) proteína H5 del virus gripal, en el que la proteína H5 consiste en o comprende una cualquiera de las secuencias expresadas en SEQ ID NOs: 2 a 12, o 35 o 36 o 40; b) un vehículo y/o excipiente farmacéuticamente aceptable. The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals, in particular for the treatment and prevention of influenza infections with H5N1 of North African origin.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNizEOgkAUBWksjHqHb6eFDQTR2mCobKTHn_WBm8Dfze5C4qGsPAIXExMPYDVTzMyj26XHwJ6sMwHjSya9gx7ouGn7oEULU0qbIt2SZccUHAfuNCQYek4XBojS41u-m5YaSmkj8NQ4bbmFX0azmluP1Y-LaH3Oy1OxgzUVvGUFQajya5wdD0m8L8sk-af5ACLPPn4</recordid><startdate>20201210</startdate><enddate>20201210</enddate><creator>GONZALEZ-HERNANDEZ, Paulino Carlos</creator><creator>REALPE-QUINTERO, Mauricio Alberto</creator><creator>STADLER, Konrad</creator><creator>VAUGHN, Eric Martin</creator><creator>LEON KEMPIS, Maria del Rocio</creator><scope>EVB</scope></search><sort><creationdate>20201210</creationdate><title>Nuevas proteínas de hemaglutinina 5 (H5) para tratamiento y prevención de infecciones gripales</title><author>GONZALEZ-HERNANDEZ, Paulino Carlos ; REALPE-QUINTERO, Mauricio Alberto ; STADLER, Konrad ; VAUGHN, Eric Martin ; LEON KEMPIS, Maria del Rocio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2798326TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>GONZALEZ-HERNANDEZ, Paulino Carlos</creatorcontrib><creatorcontrib>REALPE-QUINTERO, Mauricio Alberto</creatorcontrib><creatorcontrib>STADLER, Konrad</creatorcontrib><creatorcontrib>VAUGHN, Eric Martin</creatorcontrib><creatorcontrib>LEON KEMPIS, Maria del Rocio</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GONZALEZ-HERNANDEZ, Paulino Carlos</au><au>REALPE-QUINTERO, Mauricio Alberto</au><au>STADLER, Konrad</au><au>VAUGHN, Eric Martin</au><au>LEON KEMPIS, Maria del Rocio</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Nuevas proteínas de hemaglutinina 5 (H5) para tratamiento y prevención de infecciones gripales</title><date>2020-12-10</date><risdate>2020</risdate><abstract>Una vacuna que comprende a) proteína H5 del virus gripal, en el que la proteína H5 consiste en o comprende una cualquiera de las secuencias expresadas en SEQ ID NOs: 2 a 12, o 35 o 36 o 40; b) un vehículo y/o excipiente farmacéuticamente aceptable. The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals, in particular for the treatment and prevention of influenza infections with H5N1 of North African origin.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language spa
recordid cdi_epo_espacenet_ES2798326TT3
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Nuevas proteínas de hemaglutinina 5 (H5) para tratamiento y prevención de infecciones gripales
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T00%3A14%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GONZALEZ-HERNANDEZ,%20Paulino%20Carlos&rft.date=2020-12-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2798326TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true